These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38752574)

  • 21. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
    Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
    Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?
    Caldwell GW; Masucci JA; Yan Z; Hageman W
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.
    Jones HM; Mayawala K; Poulin P
    AAPS J; 2013 Apr; 15(2):377-87. PubMed ID: 23269526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
    Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
    Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Predictions of Nonclinical Pharmacokinetics at the Drug Design Stage.
    Stoyanova R; Katzberger PM; Komissarov L; Khadhraoui A; Sach-Peltason L; Groebke Zbinden K; Schindler T; Manevski N
    J Chem Inf Model; 2023 Jan; 63(2):442-458. PubMed ID: 36595708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine Learning guided early drug discovery of small molecules.
    Pillai N; Dasgupta A; Sudsakorn S; Fretland J; Mavroudis PD
    Drug Discov Today; 2022 Aug; 27(8):2209-2215. PubMed ID: 35364270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development.
    Heikkinen AT; Lignet F; Cutler P; Parrott N
    Proteomics Clin Appl; 2015 Aug; 9(7-8):732-44. PubMed ID: 25676057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. truPK -- human pharmacokinetic models for quantitative ADME prediction.
    Subramanian K
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery.
    Bhatia AS; Saggi MK; Kais S
    J Chem Inf Model; 2023 Nov; 63(21):6476-6486. PubMed ID: 37603536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
    Ellison CA
    Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters.
    Schneckener S; Grimbs S; Hey J; Menz S; Osmers M; Schaper S; Hillisch A; Göller AH
    J Chem Inf Model; 2019 Nov; 59(11):4893-4905. PubMed ID: 31714067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling and PBPK simulation in drug discovery.
    Jones HM; Gardner IB; Watson KJ
    AAPS J; 2009 Mar; 11(1):155-66. PubMed ID: 19280352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
    Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
    Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction.
    Liu F; Zhuang X; Yang C; Li Z; Xiong S; Zhang Z; Li J; Lu C; Zhang Z
    Biopharm Drug Dispos; 2014 Jul; 35(5):296-307. PubMed ID: 24647883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
    Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
    Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Prediction of Human Pharmacokinetics by Improving Calculation Processes of Physiologically Based Pharmacokinetic Approach.
    Mayumi K; Ohnishi S; Hasegawa H
    J Pharm Sci; 2019 Aug; 108(8):2718-2727. PubMed ID: 30876861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.